SVB Leerink reiterated coverage on AdaptHealth with a new price target
$AHCO
Medical/Nursing Services
Health Care
SVB Leerink reiterated coverage of AdaptHealth with a rating of Outperform and set a new price target of $24.00 from $32.00 previously
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 1/8/2024 | $14.50 → $8.00 | Buy → Hold | Jefferies |
| 11/8/2023 | $9.50 → $6.50 | Neutral → Underperform | BofA Securities |
| 5/10/2023 | $28.00 → $11.30 | Buy → Hold | Deutsche Bank |
| 5/10/2023 | $18.00 → $11.00 | Buy → Hold | Stifel |
| 5/9/2023 | $21.00 → $12.00 | Buy → Neutral | BofA Securities |
| 3/8/2022 | $31.00 → $26.00 | Outperform | RBC Capital |
| 3/2/2022 | $32.00 → $24.00 | Outperform | SVB Leerink |
| 2/18/2022 | $35.00 → $32.00 | Outperform | SVB Leerink |
4 - AdaptHealth Corp. (0001725255) (Issuer)
4 - AdaptHealth Corp. (0001725255) (Issuer)
3 - AdaptHealth Corp. (0001725255) (Issuer)
AdaptHealth Corp. (NASDAQ:AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, today announced the appointment of Diana Nole to the Board of Directors, effective October 16, 2024. "We are thrilled to welcome Diana to the AdaptHealth Board of Directors. Her extensive leadership experience in the healthcare technology sector caught our eye and we soon discovered that her decisive, resourceful leadership style and expertise in business transformation aligned perfectly with our current goals as an organization," said Dale Wolf, Chairman of the AdaptHealth B
Advantage Healthcare Holdings ("Advantage" or the "Company"), a regional leader in providing patient-centered healthcare through managing and operating Comprehensive Outpatient Rehabilitation Facilities and Sleep Centers, announced that its Board of Directors has named Dinak (Dino) Nair as its Chief Executive Officer. Mr. Nair assumed leadership of the Company from the prior CEO, Ryan Tong, on September 1, 2024. Mr. Nair brings over 20 years of business experience, with more than a decade as a mission-driven leader growing businesses in the healthcare market, especially in homecare, home medical equipment, diagnostic laboratory, and health system partnerships. Mr. Nair most recently served
AdaptHealth Corp. (NASDAQ:AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today the appointment of Dale Wolf as Chair of the Board of Directors, effective July 1, 2024. Mr. Wolf has served on AdaptHealth's Board since November 2019 and will assume the role from outgoing Chairman Richard Barasch. Additionally, Suzanne Foster, AdaptHealth's Chief Executive Officer, has joined the Board of Directors, effective May 20, 2024. "I am thrilled to assume the role and look forward to working alongside Suzanne and her team to leverage the momentum
AdaptHealth Corp. (NASDAQ:AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, today announced the appointment of Diana Nole to the Board of Directors, effective October 16, 2024. "We are thrilled to welcome Diana to the AdaptHealth Board of Directors. Her extensive leadership experience in the healthcare technology sector caught our eye and we soon discovered that her decisive, resourceful leadership style and expertise in business transformation aligned perfectly with our current goals as an organization," said Dale Wolf, Chairman of the AdaptHealth B
AdaptHealth Corp. (NASDAQ:AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, will release its third quarter 2024 financial results before the opening of the financial markets on Tuesday, November 5, 2024. Management will host a teleconference at 8:30 a.m. ET to discuss the results and business activities with analysts and investors. Interested parties may participate in the call by dialing: (800) 343-4136 (Domestic) or (203) 518-9843 (International) When prompted, reference Conference ID: AHCO3Q24 Webcast registration: Click Here Following the
Advantage Healthcare Holdings ("Advantage" or the "Company"), a regional leader in providing patient-centered healthcare through managing and operating Comprehensive Outpatient Rehabilitation Facilities and Sleep Centers, announced that its Board of Directors has named Dinak (Dino) Nair as its Chief Executive Officer. Mr. Nair assumed leadership of the Company from the prior CEO, Ryan Tong, on September 1, 2024. Mr. Nair brings over 20 years of business experience, with more than a decade as a mission-driven leader growing businesses in the healthcare market, especially in homecare, home medical equipment, diagnostic laboratory, and health system partnerships. Mr. Nair most recently served
SC 13D/A - AdaptHealth Corp. (0001725255) (Subject)
SC 13G/A - AdaptHealth Corp. (0001725255) (Subject)
SC 13G/A - AdaptHealth Corp. (0001725255) (Subject)
AdaptHealth Corp. (NASDAQ:AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, will release its third quarter 2024 financial results before the opening of the financial markets on Tuesday, November 5, 2024. Management will host a teleconference at 8:30 a.m. ET to discuss the results and business activities with analysts and investors. Interested parties may participate in the call by dialing: (800) 343-4136 (Domestic) or (203) 518-9843 (International) When prompted, reference Conference ID: AHCO3Q24 Webcast registration: Click Here Following the
AdaptHealth Corp. (NASDAQ:AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, will release its second quarter 2024 financial results before the opening of the financial markets on Tuesday, August 6, 2024. Management will host a teleconference at 8:30 a.m. ET to discuss the results and business activities with analysts and investors. Interested parties may participate in the call by dialing: (800) 343-4136 (Domestic) or (203) 518-9843 (International) When prompted, reference Conference ID: AHCO2Q24 Webcast registration: Click Here Followin
AdaptHealth Corp. (NASDAQ:AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, will release its first quarter 2024 financial results before the opening of the financial markets on Tuesday, May 7, 2024. Management will host a teleconference at 8:30 a.m. ET to discuss the results and business activities with analysts and investors. Interested parties may participate in the call by dialing: (800) 579-2543 (Domestic) or (785) 424-1789 (International) When prompted, reference Conference ID: AHCO1Q24 Webcast registration: Click Here Following th
Wolf has served on AdaptHealth's Board since November 2019 and will assume the role from outgoing Chairman Richard Barasch. Additionally, Suzanne Foster, AdaptHealth's Chief Executive Officer, has joined the Board of Directors, effective May 20, 2024. The Company also announced today that Josh Parnes, AdaptHealth's President and a member of the Board of Directors, will be stepping down from his role as President effective August 31, 2024 and from the Board effective December 31, 2024.
AdaptHealth (NASDAQ:AHCO) has been analyzed by 4 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish. The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 3 1 0 0 0 Last 30D 1 0 0 0 0 1M Ago 0 0 0 0 0 2M Ago 0 0 0 0 0 3M Ago 2 1 0 0 0 Analysts have recently evaluated AdaptHealth and provided 12-month price targets. The average target is $13.0, accompanied by a high estimate of $13.00
Truist Securities analyst David Macdonald maintains AdaptHealth (NASDAQ:AHCO) with a Buy and maintains $13 price target.
Jefferies downgraded AdaptHealth from Buy to Hold and set a new price target of $8.00 from $14.50 previously
BofA Securities downgraded AdaptHealth from Neutral to Underperform and set a new price target of $6.50 from $9.50 previously
Deutsche Bank downgraded AdaptHealth from Buy to Hold and set a new price target of $11.30 from $28.00 previously
8-K - AdaptHealth Corp. (0001725255) (Filer)
8-K - AdaptHealth Corp. (0001725255) (Filer)
8-K - AdaptHealth Corp. (0001725255) (Filer)